Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity Malcolm BoyceFrans van den BergSteve Warrington Clinical Trial 29 October 2016 Pages: 129 - 139
Improved participants’ understanding of research information in real settings using the SIDCER informed consent form: a randomized-controlled informed consent study nested with eight clinical trials Nut KoonrungsesomboonThipaporn TharavanijJuntra Karbwang Clinical Trial 12 November 2016 Pages: 141 - 149
Absolute oral bioavailability of selexipag, a novel oral prostacyclin IP receptor agonist Priska KaufmannNoémie HurstJasper Dingemanse Clinical Trial 24 November 2016 Pages: 151 - 156
Evaluation of 5-fluorouracil degradation rate and Pharmacogenetic profiling to predict toxicity following adjuvant Capecitabine Michela RobertoAdriana RomitiPaolo Marchetti Pharmacogenetics 18 November 2016 Pages: 157 - 164
An evaluation of the completeness of drug-drug interaction-related information in package inserts Giok Qin NgGrant Edward SklarHui Ting Chng Pharmacokinetics and Disposition 29 October 2016 Pages: 165 - 174
Effects of cytochrome P450 (CYP3A4 and CYP2C19) inhibition and induction on the exposure of selumetinib, a MEK1/2 inhibitor, in healthy subjects: results from two clinical trials Angela W. DymondKaren SoGabriella Mariani Pharmacokinetics and Disposition Open access 26 November 2016 Pages: 175 - 184
Effects of ranitidine (antacid), food, and formulation on the pharmacokinetics of fostamatinib: results from five phase I clinical studies Talia FlanaganPaul MartinMartin Kruusmägi Pharmacokinetics and Disposition 17 November 2016 Pages: 185 - 195
Monitoring of adherence to headache treatments by means of hair analysis Anna FerrariManuela LicataEnrico Silingardi Pharmacokinetics and Disposition Open access 20 November 2016 Pages: 197 - 203
Use of pharmacy dispensing data to measure adherence and identify nonadherence with oral hypoglycemic agents Fong Sodihardjo-YuenLiset van DijkMartina Teichert Pharmacoepidemiology and Prescription Open access 28 October 2016 Pages: 205 - 213
Association between antithrombotic treatment and hemorrhagic stroke in patients with atrial fibrillation—a cohort study in primary care Per WändellAxel C CarlssonKristina Sundquist Pharmacoepidemiology and Prescription Open access 08 November 2016 Pages: 215 - 221
Public confidence in ADR identification and their views on ADRreporting: mixed methods study Narumol JarernsiripornkulArunrot PatsureeJanet Krska Pharmacoepidemiology and Prescription 11 November 2016 Pages: 223 - 231
Real-world risk of diabetes with antipsychotic use in older New Zealanders: a case-crossover study Prasad S. NishtalaTe-yuan Chyou Pharmacoepidemiology and Prescription 24 November 2016 Pages: 233 - 239
Antiepileptic drug use in Italian children over a decade Daria PutignanoAntonio ClavennaMaurizio Bonati Pharmacoepidemiology and Prescription 26 November 2016 Pages: 241 - 248
Metronidazole-induced neurotoxicity presenting with sudden bilateral hearing loss, encephalopathy, and cerebellar dysfunction Elmira AgahArman HabibiAbbas Tafakhori Letter to the Editor 15 October 2016 Pages: 249 - 250
Clindamycin hydrochloride and clindamycin phosphate: two drugs or one? A retrospective analysis of a spontaneous reporting system Haona LiJianxiong DengXuequn Ren Letter to the Editor 16 November 2016 Pages: 251 - 253
Erratum to: Carriers of genetic variants in the HNF1A gene are more common among dead opioid addicts than among living addicts Anh NguyenTore B. StageKim Brøsen Erratum 07 November 2016 Pages: 255 - 255